CONNECT: Smoking Cessation and Lung Cancer Screening
This clinical trial studies the impact of CONNECT on biochemically confirmed smoking abstinence among diverse current smokers who are undergoing lung cancer screening.
Checked against the public recordLast updated Sep 15, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of California, San Francisco
- Interventions being studied
- Other: Computer-Assisted Intervention Video Doctor; Other: Computer-Assisted Intervention no Video Doctor
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age 55-80 * Male or female * English speaking * Have an already scheduled low-dose computed tomography (LDCT) visit * Smoke at least 1 cigarette in the last 7 days * Have a phone that can receive text messages. Exclusion Criteria: * Younger than 55 or older than 80 * Does not speak English * Does not have a scheduled low-dose computed tomography (LDCT) visit * Does not smoke at least 1 cigarette in the last 7 days * Does not have a phone that can receive text messages.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- San Francisco Veterans Affairs Medical CenterSan Francisco, California
- University of California, San FranciscoSan Francisco, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 15, 2023. Always confirm current availability with the study team.